Clinical Care News Round-Up – April 2023

Publication Date: 28/04/2023

Written by

Kelly Patrick

Cranfield, UK, 28th April 2023, Written by Kelly Patrick –

In this monthly news round up, I am providing some of the latest news and developments impacting the clinical care markets that caught my eye in recent weeks, including my thoughts on the implications for the market.

1. GE HealthCare gains FDA approval for CARESCAPE Canvas

Earlier in April, GE HealthCare received FDA approval for its CARESCAPE Canvas patient monitoring platform. The CARESCAPE Canvas solution enables a flexible approach to patient monitoring, enabling healthcare providers to adjust parameters provided to cater to a changing level of acuity requirements. The importance of flexible solutions was highlighted during the pandemic, with mass surges in requirements for monitoring in high acuity departments. GE HealthCare’s approach has subsequently enabled healthcare providers to adjust their platforms to cater to changes in demand across clinical settings, helping to minimize costs and maximizing solutions when required. CARESCAPE Canvas has been approved for use in the EU since June, 2022. GE HealthCare also disclosed its recent quarterly financials suggesting high single-digit (9%) growth for its Patient Care Solutions product line. This has been helped by the movement toward digital solutions to improve decision making and workflow efficiencies.

2. Ivenix Infusion system recalled by the FDA

The FDA announced a recall on the 19th April for Fresenius Kabi’s Ivenix Infusion System. The recall was provided due to a leak in the system that allows fluid to enter the Administration Set Loading Area near the Air Detector. Fresenius Kabi joins other vendors who have also faced recalls in recent years. The announcement came only days after Fresenius Kabi was awarded an Innovative Technology contract from Vizient. With safety specifications at their highest, the infusion market continues to be a difficult place to compete. Signify Research discussed the issues faced by the infusion pump vendors in an insight published earlier in the year. With increasing use of software, recalls are expected to continue but will also highlight the importance of ensuring solutions are rigorously and routinely checked for any safety defects.

3. Apple further pushing AI in health

The gossip has been flowing as Apple is reportedly in the process of further pushing AI in healthcare with its recent initiative codenamed Quartz. The service will utilize AI and data from the Apple watch to help coach individuals on personal wellness such as exercise, sleep and eating habits. Rumors also suggest that Apple will be looking to incorporate other parameters into its Apple watch such as blood pressure monitoring in 2024 and beyond. Signify Research recently reported on the ongoing battle with AliveCor over patent breaches that were made on its ECG algorithm built into the Apple iWatch. Apple is currently under a limited exclusion order (LEO) and a cease-and-desist order until a resolution to the current appeals is made.

4. AI rules the roost at HIMSS

As the Digital Health team at Signify Research predicted, the use of Artificial Intelligence in the healthcare space was high on the agenda at the HIMSS conference in April. ChatGPT was coming into its own with many vendors discussing how it can be used to aid clinical decision support. As the healthcare resource deficit echoes globally, acceptance of technology to aid clinicians with suggestive intelligence is edging closer with many vendors discussing how they will incorporate ChatGPT and other Large Language Model-based AI tools into their wider offerings. Signify Research provided its thoughts on the wider topic of AI at HIMMS in its recently published premium insight.

5. Philips announces Q1 2023 results

Philips announced their Q1 2023 sales results, showing 6% comparable sales growth on a quarter-on-quarter basis. Despite positive sales growth, the Respironics recall continues to affect operational sales with €575 million assigned to litigation costs. Proposed restructuring announced in the last six months has also hampered operations. Double-digit growth in the hospital monitoring segment drove single-digit (3%) overall growth for the Connected Care businesses. However, comparable order intake for the Connected Care business declined due to the significant orders seen during the pandemic. China recorded double digit sales, flat in the US and declining in Western Europe. Philips’ partnership with Northwell Health to standardize & centralize patient monitoring has also help to drive sales. Philips has also recently unveiled its Virtual Care Management platform which includes a ‘Comprehensive portfolio of flexible solutions and services to help health systems, providers, payers and employer groups more meaningfully motivate and deeply connect with patients from virtually anywhere’. This solution looks to be one of the first moves in improving the remote monitoring offering, by combining the attributes of Biotelemetry’s remote monitoring solutions that Philips acquired in 2020.

6. AACN and ATS Show – Signify Research is Attending!

The Signify Research Clinical Care Team will be attending the upcoming American Thoracic Society (ATS) International Conference and the NTI 2023 in May. If you would like to meet with the team – please get in touch!

About Kelly Patrick

Kelly joined Signify Research in 2020 as a Principal Analyst. She has over 15 years’ experience covering a range of healthcare technology research at IHS Markit/Omdia. Kelly’s core focus has been on the Clinical Care sector, including patient monitoring, diagnostic cardiology, respiratory care, and infusion and associated IT solutions. Kelly holds a BSc degree with honours in Pharmacology from the University of Leeds. In her spare time, Kelly has a passion for running and outings with her husband and three children.

About the Clinical Care Team

The clinical care team provides market intelligence and detailed insights on the clinical care equipment and IT markets. Our areas of coverage include patient monitoring, diagnostic cardiology, infusion pumps, ventilators, anaesthesia devices, and high-acuity IT. Our reports provide a data-centric and global outlook of each market with granular country-level insights. Our research process blends primary data collected from in-depth interviews with healthcare professionals and technology vendors, to provide a balanced and objective view of the market.

About Signify Research

Signify Research provides healthtech market intelligence powered by data that you can trust. We blend insights collected from in-depth interviews with technology vendors and healthcare professionals with sales data reported to us by leading vendors to provide a complete and balanced view of the market trends. Our coverage areas are Medical Imaging, Clinical Care, Digital Health, Diagnostic and Lifesciences and Healthcare IT.

Clients worldwide rely on direct access to our expert Analysts for their opinions on the latest market trends and developments. Our market analysis reports and subscriptions provide data-driven insights which business leaders use to guide strategic decisions. We also offer custom research services for clients who need information that can’t be obtained from our off-the-shelf research products or who require market intelligence tailored to their specific needs.

More Information